Healthcare giants increasingly develop in-house AI tools instead of buying from startups

Panelists at the Digital Healthcare Innovation Summit in Boston highlighted a growing shift among large health‑care organizations toward creating their own artificial‑intelligence solutions. Rather than purchasing off‑the‑shelf products from health‑tech startups, these institutions are opting to build custom tools in‑house.

The move is driven by a desire for greater control over data, flexibility to tailor algorithms to specific clinical workflows, and the potential to reduce long‑term licensing costs. Participants noted that while external tools can be attractive, reliance on third‑party vendors may limit adaptability and expose organizations to future pricing changes.

Analysts see this trend as a sign that major health systems are investing more heavily in internal technology capabilities, which could reshape the health‑tech market and influence how startups position their offerings.